Modeling and validating Bayesian accrual models on clinical data and simulations using adaptive priors

Slow recruitment in clinical trials leads to increased costs and resource utilization, which includes both the clinic staff and patient volunteers. Careful planning and monitoring of the accrual process can prevent the unnecessary loss of these resources. We propose two hierarchical extensions to the existing Bayesian constant accrual model: the accelerated prior and the hedging prior. The new proposed priors are able to adaptively utilize the researcher's previous experience and current accrual data to produce the estimation of trial completion time. The performance of these models, including prediction precision, coverage probability, and correct decision-making ability, is evaluated using actual studies from our cancer center and simulation. The results showed that a constant accrual model with strongly informative priors is very accurate when accrual is on target or slightly off, producing smaller mean squared error, high percentage of coverage, and a high number of correct decisions as to whether or not continue the trial, but it is strongly biased when off target. Flat or weakly informative priors provide protection against an off target prior but are less efficient when the accrual is on target. The accelerated prior performs similar to a strong prior. The hedging prior performs much like the weak priors when the accrual is extremely off target but closer to the strong priors when the accrual is on target or only slightly off target. We suggest improvements in these models and propose new models for future research.

[1]  Byron J Gajewski,et al.  Predicting accrual in clinical trials with Bayesian posterior predictive distributions , 2008, Statistics in medicine.

[2]  R. Gray,et al.  Preliminary evaluation of factors associated with premature trial closure and feasibility of accrual benchmarks in phase III oncology trials , 2010, Clinical trials.

[3]  Determinants of patient recruitment in a multicenter clinical trials group: trends, seasonality and the effect of large studies , 2001, BMC medical research methodology.

[4]  Steve,et al.  Bmc Medical Research Methodology Open Access Applications of Bayesian Approach in Modelling Risk of Malaria-related Hospital Mortality , 2003 .

[5]  K. Pile,et al.  The prevalence of underpowered randomized clinical trials in rheumatology. , 2005, The Journal of rheumatology.

[6]  H. C. Williams,et al.  Inadequate size of ‘negative’ clinical trials in dermatology , 1993, The British journal of dermatology.

[7]  J. Ibrahim,et al.  Power prior distributions for regression models , 2000 .

[8]  Vladimir V Anisimov,et al.  Modelling, prediction and adaptive adjustment of recruitment in multicentre trials , 2007, Statistics in medicine.

[9]  Byron J Gajewski,et al.  On the Existence of Constant Accrual Rates in Clinical Trials and Direction for Future Research. , 2012, International journal of statistics and probability.

[10]  Vegar Rangul,et al.  Reliability and validity of the international physical activity questionnaire in the Nord-Trøndelag health study (HUNT) population of men , 2008, BMC medical research methodology.

[11]  Qi Long,et al.  Joint monitoring and prediction of accrual and event times in clinical trials , 2012, Biometrical journal. Biometrische Zeitschrift.

[12]  T. Philipson,et al.  Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome. , 2010, The American journal of managed care.

[13]  Keying Ye,et al.  Evaluating water quality using power priors to incorporate historical information , 2006 .

[14]  Andrew Cook,et al.  A systematic review of models to predict recruitment to multicentre clinical trials , 2010, BMC medical research methodology.

[15]  Arianne P Verhagen,et al.  Survey among 78 studies showed that Lasagna's law holds in Dutch primary care research. , 2007, Journal of clinical epidemiology.

[16]  Bradley P Carlin,et al.  Hierarchical Commensurate and Power Prior Models for Adaptive Incorporation of Historical Information in Clinical Trials , 2011, Biometrics.

[17]  J. Casanovas,et al.  Clinical trial optimization: Monte Carlo simulation Markov model for planning clinical trials recruitment. , 2007, Contemporary clinical trials.

[18]  D. Saxena,et al.  Negative studies published in Indian medical journals are underpowered. , 2011, Indian pediatrics.

[19]  Michael Branson,et al.  A note on the power prior , 2009, Statistics in medicine.

[20]  Qi Long,et al.  Modeling and prediction of subject accrual and event times in clinical trials: a systematic review , 2012, Clinical trials.

[21]  R. Breau,et al.  Inadequate statistical power of negative clinical trials in urological literature. , 2006, The Journal of urology.

[22]  H. Massett,et al.  Power of an effective clinical conversation: improving accrual onto clinical trials. , 2012, Journal of oncology practice.

[23]  Rickey Edward Carter,et al.  Application of stochastic processes to participant recruitment in clinical trials. , 2004, Controlled clinical trials.

[24]  S. Senn,et al.  Some issues in predicting patient recruitment in multi‐centre clinical trials , 2013, Statistics in medicine.